A detailed history of Integrated Advisors Network LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Integrated Advisors Network LLC holds 3,439 shares of BMRN stock, worth $285,368. This represents 0.02% of its overall portfolio holdings.

Number of Shares
3,439
Previous 3,533 2.66%
Holding current value
$285,368
Previous $340,000 11.76%
% of portfolio
0.02%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 03, 2024

SELL
$83.81 - $99.0 $7,878 - $9,306
-94 Reduced 2.66%
3,439 $300,000
Q4 2023

Feb 26, 2024

BUY
$76.22 - $98.51 $15,701 - $20,293
206 Added 6.19%
3,533 $340,000
Q3 2023

Nov 16, 2023

BUY
$85.07 - $94.48 $2,126 - $2,362
25 Added 0.76%
3,327 $294,000
Q1 2023

May 05, 2023

BUY
$87.74 - $117.27 $11,406 - $15,245
130 Added 4.1%
3,302 $321,000
Q4 2022

Feb 02, 2023

BUY
$80.93 - $108.63 $256,709 - $344,574
3,172 New
3,172 $328,000

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $15.4B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Integrated Advisors Network LLC Portfolio

Follow Integrated Advisors Network LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Advisors Network LLC with notifications on news.